Año: 2019
Journal Impact Factor (JIF): 2.5720
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
CHEMISTRY, ORGANIC | SCIE | 24/57 | Q2 | T2 | D5 |
CHEMISTRY, MEDICINAL | SCIE | 36/61 | Q3 | T2 | D6 |
Año: 2019
Journal Citation Indicator (JCI): 0,880
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
CHEMISTRY, MEDICINAL | 29/70 | Q2 | T2 | D5 | 59,29 |
CHEMISTRY, ORGANIC | 15/63 | Q1 | T1 | D3 | 76,98 |
Año:
2019
CiteScore:
5,100
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Pharmaceutical Science | 37/169 | Q1 | T1 | D3 |
Clinical Biochemistry | 32/115 | Q2 | T1 | D3 |
Drug Discovery | 42/143 | Q2 | T1 | D3 |
Organic Chemistry | 49/183 | Q2 | T1 | D3 |
Biochemistry | 143/407 | Q2 | T2 | D4 |
Molecular Biology | 159/381 | Q2 | T2 | D5 |
Molecular Medicine | 72/165 | Q2 | T2 | D5 |
SJR año:
2019
Factor de Impacto:
0,640
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Pharmaceutical Science | 51/226 | Q1 | T1 | D3 |
Organic Chemistry | 62/198 | Q2 | T1 | D4 |
Drug Discovery | 60/178 | Q2 | T2 | D4 |
Clinical Biochemistry | 63/136 | Q2 | T2 | D5 |
Biochemistry | 240/491 | Q3 | T2 | D5 |
Molecular Medicine | 108/185 | Q3 | T2 | D6 |
Molecular Biology | 278/441 | Q3 | T2 | D7 |
Agencia | Código de Proyecto |
---|---|
European Development Regional Fund "A way to achieve Europe", Operative program Intelligent Growth 20142020 | - |
Institute for Translational Sciences (ITS) at UTMB | - |
Instituto de Salud Carlos III, Proyectos de Desarrollo Tecnologico en Salud | DTS17/00130 |
Instituto de Salud Carlos III, Proyectos de Investigacion en Salud | PI15/00489 |
Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia, Industria y Competitividad | - |
John Sealy Memorial Endowment Fund | - |
Plan Nacional de I+ D+ i 2013-2016 | - |
program "Nicolas Monardes" Servicio Andaluz de Salud, Junta de Andalucia | C-0059-2018 |
Sanofi Innovation Awards (iAwards) | - |
Spanish Adenovirus Network (AdenoNet) | BIO2015/68990-REDT |
Spanish Network for Research in Infectious Diseases | REIPI RD16/0016/0009 |
UTMB Technology Commercialization Program | - |
# | Autor | Afiliación |
---|---|---|
1 | Xu, Jimin | UT Medical Branch at Galveston (United States) |
2 | Pachón-Ibáñez, María Eugenia | Hospital Universitario Virgen del Rocío (Spain) |
3 | Cebrero-Cangueiro, Tania | Hospital Universitario Virgen del Rocío (Spain) |
4 | Chen, Haiying | UT Medical Branch at Galveston (United States) |
5 | Sánchez-Céspedes, Javier | Hospital Universitario Virgen del Rocío (Spain) |
6 | UT Medical Branch at Galveston (United States) |